NextCure (NASDAQ: NXTC)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of NextCure (NASDAQ: NXTC) through any online brokerage.
The latest price target for NextCure (NASDAQ: NXTC) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 13.00 expecting NXTC to rise to within 12 months (a possible 188.89% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NextCure (NASDAQ: NXTC) is $4.5 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for NextCure.
NextCure’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for NextCure.
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.